Blog
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Smith (DS) plc
Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc
Form 8.3 - The Vanguard Group, Inc.: Barratt Developments plc
EQS-News: SGT German Private Equity acquires three internet payment service providers and becomes a listed, strongly growing and profitable FinTech company
EQS-News: SGT German Private Equity acquires three internet payment service providers and becomes a listed, strongly growing and profitable FinTech company
EQS-Adhoc: SGT German Private Equity GmbH & Co. KGaA: SGT German Private Equity acquires three internet payment service providers and becomes a listed FinTech company
EQS-Adhoc: SGT German Private Equity GmbH & Co. KGaA: SGT German Private Equity acquires three internet payment service providers and becomes a listed FinTech company
Halfords Group PLC: Director/PDMR Shareholding
Halfords Group PLC: Director/PDMR Shareholding
Verve Group SE: Agenda for Verve’s Capital Markets Day 2024
Verve Group SE: Agenda for Verve’s Capital Markets Day 2024
Hardman & Co Research on Surface Transforms (SCE): Pre-close trading, AGM and prospects
Hardman & Co Research on Surface Transforms (SCE): Pre-close trading, AGM and prospects
EQS-News: USU Equips TU Braunschweig with Software Asset Management Solution
EQS-News: USU Equips TU Braunschweig with Software Asset Management Solution
EQS-News: Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
EQS-News: Eckert & Ziegler becomes European contract manufacturer for Telix's innovative Phase III ProstACT GLOBAL study
EQS-News: clearvise AG publishes half-year financial report 2024 and confirms outlook
EQS-News: clearvise AG publishes half-year financial report 2024 and confirms outlook
EQS-News: DEFENCE THERAPEUTICS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER ADVANCES
EQS-News: DEFENCE THERAPEUTICS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER ADVANCES
EQS-News: secunet Security Networks AG publishes Half-Year Financial Report 2024 and confirms forecast for the full year
EQS-News: secunet Security Networks AG publishes Half-Year Financial Report 2024 and confirms forecast for the full year
EQS-News: CANCOM: CANCOM Group holds its own in a challenging market environment
EQS-News: CANCOM: CANCOM Group holds its own in a challenging market environment
Destiny Pharma plc shares now trading on JP Jenkins
Destiny Pharma plc shares now trading on JP Jenkins
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
EQS-News: INDUS performs in line with expectations in a difficult environment
EQS-News: INDUS performs in line with expectations in a difficult environment
EQS-News: Medios AG continues its growth trajectory in the first half of 2024 and records disproportionately high increase in earnings
EQS-News: Medios AG continues its growth trajectory in the first half of 2024 and records disproportionately high increase in earnings
EQS-News: Henkel delivers good organic sales growth and very strong earnings improvement in first half of 2024
EQS-News: Henkel delivers good organic sales growth and very strong earnings improvement in first half of 2024
EQS-News: hGears AG Group: Results in the first half of 2024 in line with expectations despite economic weakness and ongoing destocking
EQS-News: hGears AG Group: Results in the first half of 2024 in line with expectations despite economic weakness and ongoing destocking
EQS-News: Semperit increases profitability in the first half of 2024
EQS-News: Semperit increases profitability in the first half of 2024
EQS-News: GESCO SE publishes half-year report 2024
EQS-News: GESCO SE publishes half-year report 2024
EQS-News: Mutares increases consolidated revenues by 15% in the first half of the year and once again achieves positive Adjusted EBITDA – forecast for full year 2024 confirmed
EQS-News: Mutares increases consolidated revenues by 15% in the first half of the year and once again achieves positive Adjusted EBITDA – forecast for full year 2024 confirmed
EQS-News: Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
EQS-News: Evotec announces strong progress in strategic protein degradation partnership with Bristol Myers Squibb
EQS-News: H1 2024 results: RENK Group AG continues successful business development with record figures – more precisely defined financial guidance at upper end of the forecast range
EQS-News: H1 2024 results: RENK Group AG continues successful business development with record figures – more precisely defined financial guidance at upper end of the forecast range
EQS-News: DATAGROUP with higher sales momentum in the third quarter – Full-year forecast entirely confirmed
EQS-News: DATAGROUP with higher sales momentum in the third quarter – Full-year forecast entirely confirmed


